Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HC.3ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
HC.3ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
HC.3ORF1abChan-ORF1abGTGTGATGTTGAWATGACATGGTC2441.671635316330R-14069.5China
HC.3ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17655.9Hong Kong
HC.3SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
HC.3SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-22073.5China
HC.3SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
HC.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HC.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HC.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HC.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HC.3NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
HC.3NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
HC.3NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
HC.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-15983.3US
HC.3NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
HC.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HC.3NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
HC.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HC.3NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
HC.3NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
HC.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HC.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HC.3ORF1abNIID WH-1 F501R913CTTTACCAGCACGTGCTAGAAGG2352.17896874R-25657.5Japan
HC.3ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-21257.9Japan
HC.3ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
JN.1.7.7SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
JN.1.7.7SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-22073.5China
JN.1.7.7SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
JN.1.7.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.7.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.7.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.7.7NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.1.7.7NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
JN.1.7.7NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
JN.1.7.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.7.7NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
JN.1.7.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.7.7NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
JN.1.7.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.7.7NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
JN.1.7.7NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
JN.1.7.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.7.7NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.7.7ORF1abNIID WH-1 F501R913CTTTACCAGCACGTGCTAGAAGG2352.17896874R-26378.9Japan
JN.1.7.7ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-21257.9Japan
JN.1.7.7ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
JN.1.7.7SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-4850.04Japan
JN.1.7.7SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-4117.64Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used